![ORCID 0000-0001-5677-8979](/images/orcid_16x16.gif)
![ORCID 0000-0002-8309-094X](/images/orcid_16x16.gif)
![ORCID 0000-0003-2076-2195](/images/orcid_16x16.gif)
![ORCID 0000-0002-6129-15720000-0002-6129-1572](/images/orcid_16x16.gif)
![ORCID 0000-0002-9931-0580](/images/orcid_16x16.gif)
![ORCID 0000-0003-0655-885X](/images/orcid_16x16.gif)
![ORCID 0000-0001-7516-3179](/images/orcid_16x16.gif)
![ORCID 0000-0001-6052-6061](/images/orcid_16x16.gif)
![ORCID 0000-0003-1530-5811](/images/orcid_16x16.gif)
![ORCID 0000-0003-4759-3686](/images/orcid_16x16.gif)
![ORCID 0000-0002-9476-7143](/images/orcid_16x16.gif)
![ORCID 0000-0002-4510-7341](/images/orcid_16x16.gif)
![ORCID 0000-0002-2064-9603](/images/orcid_16x16.gif)
![ORCID 0000-0002-8532-5087](/images/orcid_16x16.gif)
![ORCID 0000-0002-2581-484X](/images/orcid_16x16.gif)
![ORCID 0000-0001-5177-3431](/images/orcid_16x16.gif)
![ORCID 0000-0002-7892-193X](/images/orcid_16x16.gif)
![ORCID 0000-0002-4303-7685](/images/orcid_16x16.gif)
![ORCID 0000-0002-8448-1264](/images/orcid_16x16.gif)
![ORCID 0000-0001-9800-5296](/images/orcid_16x16.gif)
![ORCID 0000-0003-2229-1120](/images/orcid_16x16.gif)
Dokumentenart: | Artikel | ||||
---|---|---|---|---|---|
Titel eines Journals oder einer Zeitschrift: | Kidney International | ||||
Verlag: | Elsevier | ||||
Ort der Veröffentlichung: | NEW YORK | ||||
Band: | 99 | ||||
Nummer des Zeitschriftenheftes oder des Kapitels: | 4 | ||||
Seitenbereich: | S. 926-939 | ||||
Datum: | 2021 | ||||
Institutionen: | Medizin > Abteilung für Nephrologie Medizin > Institut für Epidemiologie und Präventivmedizin > Lehrstuhl für Genetische Epidemiologie | ||||
Identifikationsnummer: |
| ||||
Stichwörter / Keywords: | GLOMERULAR-FILTRATION-RATE; ASSOCIATION; DISEASE; TYPE-2; MORTALITY; LOCI; ALBUMINURIA; PROGRESSION; GENE; CKD; acute kidney injury; end-stage kidney disease; genome-wide association study; rapid eGFRcrea decline | ||||
Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
Status: | Veröffentlicht | ||||
Begutachtet: | Ja, diese Version wurde begutachtet | ||||
An der Universität Regensburg entstanden: | Ja | ||||
Dokumenten-ID: | 56751 |
Zusammenfassung
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to ...
![plus plus](/style/images/plus.png)
Zusammenfassung
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m(2)/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m(2) at follow-up among those with eGFRcrea 60 mL/min/1.73m(2) or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or (LARP4B). Individuals at high compared to those at low genetic risk (8-14 vs. 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.
Metadaten zuletzt geändert: 29 Feb 2024 12:37